Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display.
Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdow...
Main Authors: | Caitlin N Suire, Sarah Nainar, Michael Fazio, Adam G Kreutzer, Tara Paymozd-Yazdi, Caitlyn L Topper, Caroline R Thompson, Malcolm A Leissring |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5814047?pdf=render |
Similar Items
-
Insulin-Degrading Enzyme: Paradoxes and Possibilities
by: Malcolm A. Leissring
Published: (2021-09-01) -
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
by: Leissring Malcolm A, et al.
Published: (2009-01-01) -
Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
by: Christelle Cabrol, et al.
Published: (2009-01-01) -
Quantitative, High-Throughput Assays for Proteolytic Degradation of Amylin
by: Caitlin N. Suire, et al.
Published: (2020-11-01) -
Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).
by: Duanwen Shen, et al.
Published: (2013-01-01)